Provided by Tiger Trade Technology Pte. Ltd.

Invesco Financial Preferred ETF

12.69
+0.08000.63%
Post-market: 12.690.00000.00%19:30 EDT
Volume:365.67K
Turnover:4.62M
Market Cap:602.78M
PE:8.43
High:12.70
Open:12.60
Low:12.59
Close:12.61
52wk High:14.74
52wk Low:12.58
Shares:47.50M
Float Shares:47.50M
Volume Ratio:1.55
T/O Rate:0.77%
Dividend:0.87
Dividend Rate:6.88%
EPS(TTM):1.51
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Scotts Miracle-Gro Price Target Cut to $60.00/Share from $77.00 by Wells Fargo

Dow Jones
·
Oct 05

Clorox Price Target Cut to $85.00/Share from $90.00 by Wells Fargo

Dow Jones
·
Oct 05

Church & Dwight Price Target Cut to $105.00/Share from $110.00 by Wells Fargo

Dow Jones
·
Oct 05

Hershey is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
Oct 05

Mondelez is Maintained at Overweight by Wells Fargo

Dow Jones
·
Oct 05

Bank of America Raises Indirect Stake in Adese Through Merrill Lynch Trades

TIPRANKS
·
Oct 05

Bank of America Raises Indirect Stake in Turkish Gold Miner Koza Altin

TIPRANKS
·
Oct 05

Bank of America Lifts Indirect Stake in A1 Yenilenebilir Enerji to 3%

TIPRANKS
·
Oct 05

Molson Coors Beverage Price Target Cut to $38.00/Share from $41.00 by Wells Fargo

Dow Jones
·
Oct 05

Triple Flag Precious Metals (TFPM) Receives a Buy from Bank of America Securities

TIPRANKS
·
Oct 05

Bank of America Securities Remains a Buy on BCE (BCE)

TIPRANKS
·
Oct 05

Constellation Brands is Maintained at Overweight by Wells Fargo

Dow Jones
·
Oct 05

Anheuser-Busch InBev is Maintained at Overweight by Wells Fargo

Dow Jones
·
Oct 05

UBS Adjusts Price Target on Wells Fargo to $102 From $104, Keeps Buy Rating

MT Newswires Live
·
Oct 05

Synopsys enters $1B accelerated share repurchase agreement

TIPRANKS
·
Oct 05

Wells Fargo Sticks to Its Buy Rating for Beam Therapeutics (BEAM)

TIPRANKS
·
Oct 05

Wells Fargo Sticks to Its Hold Rating for Crispr Therapeutics AG (CRSP)

TIPRANKS
·
Oct 05

Press Release: Wells Fargo to Announce Third Quarter 2026 Earnings on Oct. 13, 2026

Dow Jones
·
Oct 05

Wells Fargo Sticks to Their Hold Rating for Intellia Therapeutics (NTLA)

TIPRANKS
·
Oct 05

Wells Fargo Keeps Their Buy Rating on Arcturus Therapeutics (ARCT)

TIPRANKS
·
Oct 05